Murray Stahl’s Gilead Sciences GILD Stock Holding History

Murray Stahl’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-9,000	Closed	-$674K	–	335
2023 Q3	$674K	Sell	9,000 -33	-0.4%	-$2.54K	0.01%	190
2023 Q2	$696K	Buy	9,033 +33	+0.4%	+$2.63K	0.02%	191
2023 Q1	$747K	Hold	9,000	–	–	0.01%	179
2022 Q4	$773K	Hold	9,000	–	–	0.01%	176
2022 Q3	$555K	Hold	9,000	–	–	0.01%	202
2022 Q2	$556K	Hold	9,000	–	–	0.01%	206
2022 Q1	$535K	Sell	9,000 -2,017	-18%	-$129K	0.01%	228
2021 Q4	$800K	Hold	11,017	–	–	0.02%	198
2021 Q3	$770K	Hold	11,017	–	–	0.02%	203
2021 Q2	$759K	Hold	11,017	–	–	0.02%	205
2021 Q1	$712K	Hold	11,017	–	–	0.02%	211
2020 Q4	$642K	Sell	11,017 -900	-8%	-$54.3K	0.02%	213
2020 Q3	$753K	Hold	11,917	–	–	0.03%	194
2020 Q2	$917K	Buy	11,917 +17	+0.1%	+$1.3K	0.03%	172
2020 Q1	$890K	Buy	11,900 +900	+8%	+$62.2K	0.04%	152
2019 Q4	$715K	Hold	11,000	–	–	0.02%	207
2019 Q3	$697K	Sell	11,000 -200	-2%	-$13.1K	0.02%	216
2019 Q2	$757K	Buy	11,200 +1,200	+12%	+$78.9K	0.02%	211
2019 Q1	$650K	Buy	+10,000	New	+$665K	0.02%	231

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Murray Stahl's GILD Position: Q4 2023 in Review

Murray Stahl sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 9,000 shares — an estimated $674K sold.

Murray Stahl first reported a position in GILD in Q1 2019 and held it in 19 quarters. The position peaked at $917K in Q2 2020. 1,776 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

Murray Stahl reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
Murray Stahl sold 9,000 Gilead Sciences shares in Q4 2023, an estimated $674K.
Murray Stahl first reported a position in Gilead Sciences in Q1 2019 and held it in 19 quarters.
Murray Stahl's Gilead Sciences position peaked at $917K in Q2 2020.
1,776 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on Horizon Kinetics Asset Management's 13F filing for Q4 2023, filed 15 Feb 2024.